Frontiers in Pharmacology,
Год журнала:
2025,
Номер
16
Опубликована: Фев. 26, 2025
Emodin
has
shown
certain
anti-rheumatoid
arthritis
(RA)
activity
in
preliminary
studies.
However,
the
precise
mechanisms
of
emodin's
anti-RA
effects,
particularly
its
direct
targets,
remain
unclear.
This
study
aimed
to
evaluate
emodin
and
elucidate
potential
mechanisms,
with
a
specific
focus
on
identifying
molecular
targets.
Employing
collagen-induced
(CIA)
rat
model,
along
transcriptomic
analysis,
thermal
proteome
profiling
(TPP)
TNF-α-induced
L929
cell
was
confirmed,
TNF-α
as
target.
Techniques
such
drug
affinity
responsive
target
stability
(DARTS),
cellular
shift
assay
(CETSA),
Affinity
ultrafiltration-liquid
chromatography/mass
spectrometry
(AUF-LC/MS),
surface
plasmon
resonance
(SPR)
bio-layer
interferometry
(BLI)
validated
binding
TNF-α.
Molecular
dynamics
simulation,
ELISA
BLI
further
revealed
that
stabilizes
asymmetric
trimeric
structure
TNF-α,
disrupting
TNF-α-TNFR1
interaction.
In
vitro
assays,
including
luciferase
reporter
gene
MH7A
demonstrated
this
disruption
inhibits
NF-κB
activation,
leading
downregulation
inflammatory
mediators
IL-6,
IL-1β,
COX2.
conclusion,
directly
targets
stabilizing
blocking
interaction,
which
subsequently
suppresses
downstream
pathway
activation
contributes
potent
properties.
Nanoscale,
Год журнала:
2024,
Номер
16(32), С. 14975 - 14993
Опубликована: Янв. 1, 2024
Rheumatoid
arthritis
(RA)
is
a
progressive
autoimmune
disease
that
mainly
affects
the
inner
lining
of
synovial
joints
and
leads
to
chronic
inflammation.
While
RA
not
known
as
lethal,
recent
research
indicates
it
may
be
silent
killer
because
its
strong
association
with
an
increased
risk
lung
heart
diseases.
Patients
develop
these
systemic
consequences
due
regular
uptake
heavy
drugs
such
disease-modifying
antirheumatic
medications
(DMARDs),
glucocorticoids
(GCs),
nonsteroidal
anti-inflammatory
medicines
(NSAIDs),
Communications Biology,
Год журнала:
2025,
Номер
8(1)
Опубликована: Апрель 29, 2025
Atherosclerosis
is
a
chronic
inflammatory
disease
that
strongly
threatens
human
health,
and
macrophages
play
pivotal
role
in
its
pathogenesis.
Ubiquitin-specific
peptidase
22
(USP22)
involved
the
regulation
of
macrophage
inflammation.
However,
atherosclerotic
microenvironment
remains
unclear.
In
this
study,
we
found
USP22
overexpression
alleviated
atherosclerosis
progression
ApoE-/-
mice.
vitro,
silencing
enhanced
inflammation
foam
cell
formation,
efferocytosis
was
significantly
impaired.
Mechanistically,
bound
to
peroxisome
proliferator-activated
receptor
γ
(PPARγ)
inhibited
ubiquitination,
thereby
stabilizing
PPARγ
promoting
efferocytosis.
addition,
intraperitoneal
injection
inhibitor
USP22i-S02
exacerbated
summary,
these
findings
indicate
may
be
potential
therapeutic
target
for
treatment
atherosclerosis.
Frontiers in Medicine,
Год журнала:
2025,
Номер
12
Опубликована: Май 9, 2025
Background
Diabetic
retinopathy
(DR),
one
of
the
most
common
complications
diabetes,
severely
impacts
patients’
quality
life.
The
combined
use
traditional
Chinese
medicines
Astragalus,
Fructus
ligustris,
and
Cornus
officinalis
has
yielded
considerable
therapeutic
effects
in
clinical
DR
treatment.
Methods
In
this
study,
a
multimodule
framework
(BNM)
encompassing
bioinformatics,
network
pharmacology,
machine
learning
(ML)
based
on
molecular
fingerprints
was
innovatively
developed
to
thoroughly
investigate
mechanisms
medicine
treating
DR.
Results
A
total
40
active
components
12
core
targets
were
identified.
Enrichment
analysis
identified
key
pathways
such
as
VEGF
signaling
pathway,
TNF
pathway
HIF-1
pathway.
Prediction
models
using
targets,
PPARG,
constructed
from
GEO
database
validated
via
immune
infiltration
docking,
revealing
that
PPARG
may
be
potential
target
for
Moreover,
component
medicine,
stigmasterol,
ML
model
fingerprints.
vivo
experiments
demonstrated
stigmasterol
can
regulate
glucose
lipid
metabolism,
improve
systemic
inflammatory
levels,
ameliorate
ocular
vascular
changes
by
modulating
expression
PPARG.
Conclusion
BNM
suggests
an
important
treatment
DR,
with
its
mechanism
potentially
related
VEGF/VEGFR